Clinical trial
Efficacy and Tolerability of Memantine in Frontotemporal Dementia (FTD) Patients
NCT00200538 · Nantes University Hospital, Other · Completed
Key facts
| NCT number | NCT00200538 |
|---|---|
| Title | Efficacy and Tolerability of Memantine in Frontotemporal Dementia (FTD) Patients |
| Official title | Double-blind, Parallel Group, Placebo-controlled Trial of the Efficacy and Tolerability of Memantine (20 mg) in Frontotemporal Dementia (FTD) Patients |
| Lead sponsor | Nantes University Hospital, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Dementia |
| Intervention type | Drug |
| Interventions | memantine |
| Enrollment | 52 |
| Start date | Sep 1, 2005 |
| First posted | Sep 20, 2005 |
| Last update posted | May 3, 2013 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: